Search
thewest.com.au
BusinessChevron Right Icon

Health

Perth acquisitionCommentsPremium‘Strong M&A interest in IVF market’: Monash chief

Monash IVF Group chief executive Michael Knaap says there is strong M&A interest in the sector despite some COVID-related uncertainty, as the company revealed it had gained a foothold in the WA market.

Danielle Le Messurier

Expansion plansCommentsPremiumPerth IVF company snapped up in $40m deal

East coast-based City Fertility has bought Perth’s Fertility Specialists of WA and plans to invest $10m in new facilities and specialist staff.

Cheyanne Enciso

Regulator oversightCommentsPremiumUnaffordable and unavailable insurance in APRA’s sights

Insurance companies have been put on notice that regulators will pursue them for poor value policies or product design in the face of climate change and rising health costs.

Adrian Lowe

Huge pressure CommentsPremiumThree WA hospitals declare code yellow as COVID cases surge

Three of WA’s largest hospitals called code yellows on Wednesday— a sign the State’s health system continues to struggle with unprecedented pressure as COVID cases surge.

Kellie Balaam and Briana Fiore

CEO calls timeCommentsPremiumHBF looking for new boss as John Van Der Wielen steps down

The former investment banker has shaken up WA’s biggest private health insurer since taking the helm in 2017.

Sean Smith

Discretion needed CommentsPremiumPerth pair put intelligence in artificial intelligence

As more companies look to speed up their processes with automation technology and artificial intelligence, two Perth founders stress retaining the human element is key.

Caitlin Paroczai

New assetCommentsPremiumSweat-stopper gel a sweet deal for Perth’s Botanix

Shares in Perth dermatology company Botanix Pharmaceuticals have surged after it announced the acquisition of a new drug that will help treat a medical condition which causes excessive underarm sweating.

Cheyanne Enciso

Quick actionCommentsPremiumHealth tech key to helping understaffed aged care nurses

Health tech could play a vital role in improving Australia’s aged care system and supporting understaffed nursing homes, a Perth founder has said.

Caitlin Paroczai

Earnings hit CommentsPremiumRamsay profit tumbles on staff absenteeism, restrictions

Takeover target Ramsay Health Care has revealed its business was significantly disrupted in the third quarter as a result of COVID-related staff absenteeism, surgical restrictions in WA and soaring costs.

Danielle Le Messurier

Jobs bonanzaPremiumSt John of God, APM chase overseas staff to fill vacancies

The private health operator and employment and disability services provider need more than 1000 staff to meet demand for their services and support virus-fatigued workforces.

Sean Smith

Hearing aidsCommentsPremiumNuheara strikes trademark licence agreement with HP

Nuheara has struck a deal with leading PC manufacturer HP to develop, manufacture and market its hearing aid products under HP brand trademarks. However, investors are not convinced of the move.

Danielle Le Messurier

‘Underpriced’ offerCommentsPremium‘Hung out to dry’: ResApp investors unleash over Pfizer bid

The chief executive of digital health company ResApp Health has defended the board’s decision to recommend shareholders support a $100 million takeover offer from Pfizer Australia. 

Danielle Le Messurier

Expanding model CommentsPremiumEmyria flags expanding data system beyond medicinal cannabis

Emyria could eventually expand its clinical trial-grade data system — used to accelerate the development of its medicinal cannabis and psychedelic treatments — to assist other companies.

Danielle Le Messurier

Right fit CommentsPremiumGenomic testing key to right treatment, biotech founders say

The founders of a Perth biotech company say genetic testing could be the key to ensuring patients receive more accurate mental health treatment, as support for the medical tool gains momentum.

Caitlin Paroczai

Consortium partnerCommentsPremiumHealth super giant part of $20b bid for Ramsay

Health Employees Superannuation Trust Australia has confirmed it is part of a KKR consortium that offered $20.1 billion to buy hospital operator Ramsay Health Care.

Matthew Burgess

Healthcare bidCommentsPremiumHBF chief says Ramsay bid reflects public health pressures

A private equity-led consortium has lobbed a proposed $88-a-share offer for Australia’s biggest listed healthcare group.

Sean Smith

Due diligenceCommentsPremiumKKR-led group makes $20 billion bid for Ramsay Health

A consortium led by KKR offered to buy Ramsay Health Care for $20.1 billion, chasing a network of private hospitals across Australia and Europe treating millions of patients a year.

Angus Whitley

Urgent need CommentsPremiumThe WA medical company fixing the hearing loss crisis

In Perth’s burgeoning medical technology and life sciences hub of Nedlands, a push to fix Australia’s growing hearing loss crisis is gathering pace.

Adrian Lowe

Bowled overCommentsPremiumHuge amount it will cost Perth bowls club to remove asbestos

Removing all of the asbestos from the Mt Pleasant Bowling Club building would cost Melville ratepayers more than what was first budgeted for its much-needed renovation.

Matt Zis

The West Australian exclusive
The West Australian exclusive
Short stint Premium
The West Australian exclusive
Ex-health boss Cowan quits start-up after shock charges

A Queensland start-up focused on face masks says ex-Joondalup Health Campus boss Kempton Cowan had little to do with it before resigning as a director last week following charges linked to child abuse material.

Sean Smith

Limits removedCommentsPremiumMore COVID-19 restrictions lifted ahead of Easter

Limits on private outdoor and home gatherings lift from midnight along with the 500 patron at pubs and clubs rule, while the close contact definition has been tightened, the Premier has announced.

Rebecca Le May

Breakfast with ...CommentsPremiumWhy being in Perth is a ‘superpower’ for this startup

INSIDER: Katharine Giles, the chief executive of thriving medical technology startup OncoRes Medical, is charting her own course in a place where naysayers said it couldn’t be done.

Adrian Lowe

Zoom boomCommentsPremiumHow COVID left economic scar but left us with glowing skin

INSIDER: The height of the COVID-19 pandemic plunged the world into economic uncertainty and stripped it of normality — but boy, was our skin glowing.

Jade Jurewicz

Mixed reception CommentsPremiumPfizer’s $100m play for ResApp Health ‘underpriced’

A recommendation by the board of ResApp that shareholders back Pfizer Australia’s $100 million play for the company has been given a mixed reception, with some calling the bid an insult to long-term investors.

Danielle Le Messurier